SCHEMBL7337753

SCHEMBL7337753

Cc1ccc(-c2ccc(C)c(CCl)c2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.39
KMT2A Q03164 2/20 0.37
NPSR1 Q6W5P4 1/20 0.37
MEN1 O00255 1/20 0.36
TP53 P04637 1/20 0.36
MCL1 Q07820 1/20 0.35
CA12 O43570 1/20 0.34
CA9 Q16790 1/20 0.34
PON1 P27169 1/20 0.34
TDP1 Q9NUW8 3/20 0.33
ICMT O60725 1/20 0.33
ACHE P22303 1/20 0.33
AR P10275 1/20 0.33
HPGD P15428 2/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
ALOX15 P16050 1/20 0.32
CYP2C19 P33261 1/20 0.32
HSD17B10 Q99714 1/20 0.32
ALDH1A1 P00352 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2139060 0.86 HPGD (0.42) TAAR1HPGDALDH1A1
SCHEMBL7330961 0.83 HPGD (0.44) TAAR1KMT2AMEN1TP53MCL1
SCHEMBL1030033 0.82 TAAR1 (0.56) TAAR1KMT2ANPSR1TP53PON1
SCHEMBL5354908 0.80 TAAR1 (0.54) TAAR1KMT2ANPSR1MEN1TP53
SCHEMBL7662696 0.79 TAAR1 (0.39) TAAR1KMT2AMEN1TP53MCL1
SCHEMBL2809167 0.75 EGFR (0.48) KMT2AMEN1CA12CA9TDP1
SCHEMBL19512763 0.73 RXRA (0.49) KMT2AMEN1TP53MCL1ICMT
SCHEMBL1047499 0.72 TDP1 (0.46) MCL1TDP1ACHEARALDH1A1
SCHEMBL7673877 0.72 ALOX5 (0.44) HPGDCYP3A4
SCHEMBL16215286 0.72 TAAR1 (0.34) TAAR1KMT2AMEN1TP53MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5545645-A Heterocyclic derivatives in the treatment of ischaemia and related diseases SYNTEX PHARMACEUTICALS, LIMITED (GB) 1996-08-13 US disclosed
EP-0693062-A1 HETEROCYCLIC DERIVATIVES IN THE TREATMENT OF ISCHAEMIA AND RELATED DISEASES SYNTEX PHARMACEUTICALS LTD. (GB) 1996-01-24 EP disclosed
US-5428037-A Piperazine derivatives; calcium and sodium channel antagonists SYNTEX PHARMACEUTICALS, LTD. (GB) 1995-06-27 US disclosed
WO-1994024116-A1 HETEROCYCLIC DERIVATIVES IN THE TREATMENT OF ISCHAEMIA AND RELATED DISEASES SYNTEX PHARMACEUTICALS LIMITED (GB) 1994-10-27 WO disclosed